TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,167,965 | -4.4% | 533,157 | -2.0% | 3.62% | +2.9% |
| Q2 2023 | $8,546,900 | -4.4% | 544,042 | +0.3% | 3.52% | -7.5% |
| Q1 2023 | $8,937,796 | +7.9% | 542,342 | +2.2% | 3.81% | +7.0% |
| Q4 2022 | $8,281,759 | +25.9% | 530,882 | +4.7% | 3.56% | +16.5% |
| Q3 2022 | $6,577,000 | -4.2% | 507,128 | +3.7% | 3.05% | +7.6% |
| Q2 2022 | $6,863,000 | +90.8% | 488,835 | +94.6% | 2.84% | +123.4% |
| Q1 2022 | $3,597,000 | +44862.5% | 251,220 | +67432.3% | 1.27% | +42233.3% |
| Q1 2019 | $8,000 | – | 372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |